Research | Volume 37, Article 328, 08 Dec 2020 | 10.11604/pamj.2020.37.328.20245

Urinary tract infections and associated factors in HIV infected pregnant women at a tertiary hospital in Lusaka, Zambia

Moses Mukosha, Lukundo Nambela, Chiluba Mwila, Micheal Chigunta, Aubrey Chichonyi Kalungia, Mwansa Ketty Lubeya, Bellington Vwalika

Corresponding author: Moses Mukosha, Department of Pharmacy, The University of Zambia, Lusaka, Zambia

Received: 02 Sep 2019 - Accepted: 03 Mar 2020 - Published: 08 Dec 2020

Domain: Obstetrics and gynecology

Keywords: Urinary tract infection, Zambia, prevalence, HIV, pregnancy, gestational age, booking, antenatal care, asymptomatic bacteriuria

©Moses Mukosha et al. Pan African Medical Journal (ISSN: 1937-8688). This is an Open Access article distributed under the terms of the Creative Commons Attribution International 4.0 License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Cite this article: Moses Mukosha et al. Urinary tract infections and associated factors in HIV infected pregnant women at a tertiary hospital in Lusaka, Zambia. Pan African Medical Journal. 2020;37:328. [doi: 10.11604/pamj.2020.37.328.20245]

Available online at: https://www.panafrican-med-journal.com/content/article/37/328/full

Home | Volume 37 | Article number 328

Research

Urinary tract infections and associated factors in HIV infected pregnant women at a tertiary hospital in Lusaka, Zambia

Urinary tract infections and associated factors in HIV infected pregnant women at a tertiary hospital in Lusaka, Zambia

Moses Mukosha1,2,&, Lukundo Nambela3, Chiluba Mwila1, Micheal Chigunta3, Aubrey Chichonyi Kalungia1, Mwansa Ketty Lubeya4, Bellington Vwalika4

 

1Department of Pharmacy, The University of Zambia, Lusaka, Zambia, 2Mosi-o-Tunya University of Science and Technology, Lusaka, Zambia, 3Faculty of Pharmacy Nutrition and Dietetics, Apex Medical University, Lusaka, Zambia, 4Department of Obstetrics and Gynecology, The University of Zambia, Lusaka, Zambia

 

 

&Corresponding author
Moses Mukosha, Department of Pharmacy, The University of Zambia, Lusaka, Zambia

 

 

Abstract

Introduction: urinary tract infections (UTIs) remain among significant causes of morbidity and mortality in pregnant women in sub-Saharan Africa. Zambia shares this burden disproportionately compared to other countries and it is unknown to what extent HIV affects UTIs. This study investigated the prevalence of UTIs and associated factors among HIV infected pregnant women attending antenatal care at a tertiary hospital in Zambia.

 

Methods: we conducted a retrospective review of medical records of Zambian HIV infected pregnant women who attended antenatal care at the women and newborn hospital between 1st January 2017 and 31st December 2017. We used a structured data extraction tool to extract data from the patient medical records using simple random sampling without replacement. Medical records of patients with known, diabetes and renal transplant were excluded. A logistic regression model was used to establish factors associated with UTIs.

 

Results: we reviewed 380 medical records of pregnant women with a median age of 29 years (IQR: 22, 34). UTIs prevalence was 16.5%, (95% CI: 13.0, 20.7). Women with UTIs had lower gestational age than those without UTI (difference 3 weeks, P<0.0001). Gestational age was independently associated with UTI (AOR: 0.96, 95% Cl: 0.91-0.99).

 

Conclusion: the burden of UTIs in this population was high compared to global estimates and gestational age predicts UTIs. Public health interventions should be directed at promoting an early screening of UTIs during pregnancy, preferably to educate HIV positive women to book for antenatal early so that screening could commence.

 

 

Introduction    Down

Urinary tract infections (UTIs) are responsible for increased pregnancy-related morbidities in HIV infected women [1-3]. Complications of UTIs in pregnancy have been well studied in developed countries, and high rates of maternal and perinatal morbidities have been reported [4,5]. The maternal and perinatal morbidities related to UTIs vary for different settings, though little has been done in sub-Saharan Africa [6].

 

A recent study in Tanzania [1] reported a rising trend of UTIs, from approximately 15% in 2009 to 21%, in 2017 with a preponderance of UTIs in the vulnerable HIV infected pregnant women. Other studies have reported that women with HIV infection have a threefold-greater risk of experiencing UTIs than HIV-negative women [7,8]. The reduced immune system associated with HIV infection may account for this increase in the observed UTIs.

 

Several studies have documented various predictors of UTIs [9-11]. Among the factors reported to be associated with UTIs are, single marital status, CD4 count below 200 cells/ μL and the presence of symptoms predicted UTIs [12,13]. The reported association between low CD4+ counts with UTI among HIV-infected pregnant women can be explained by the severity of immunosuppression and the increased likelihood for opportunistic conditions and/infections, including UTI, preeclampsia, oxidative stress [14-16]. Contrary, other studies have shown no association between UTI and marital status [17,18]. The lack of association with marital status can be attributable to the differences in cultural practice, hygiene and norms on sex issues in different areas [19].

 

UTIs are common among HIV-infected pregnant women and if left untreated, can lead to poor maternal and foetal outcomes [19-21]. Additionally, 20% to 30% of affected women may develop acute pyelonephritis [22,23] which may lead to septicaemia, anaemia, premature rupture of membranes, renal dysfunction, transient preterm labour, intrauterine growth restriction (IUGR), low birth weight and preeclampsia [24,25]. Additionally, asymptomatic bacteriuria (ASB) places the women at risk of preterm birth and delivery of low birth weight infants [26]. Despite the evidence of high prevalence rates of UTIs in HIV infected population, in other settings, there is a paucity of data on associated factors in the Zambian HIV infected pregnant women population. This study investigated the prevalence of UTIs and associated factors in HIV infected pregnant women at a tertiary hospital in Lusaka, Zambia.

 

 

Methods Up    Down

Study design and setting: we conducted a retrospective review of medical records of Zambian HIV infected pregnant women attending antenatal care between 1st January 2017 and 31st December 2017. This study was conducted at the Women and Newborn Teaching Hospital of the University Teaching Hospitals in Lusaka urban, Zambia. The hospital is the largest referral centre in Zambia for obstetrics conditions. On average, the hospital attends to 28,800 pregnant women each year and about 18,000 births are recorded at this hospital annually. It receives referrals from over 25 clinics from the surrounding areas of Lusaka and the rest of the country.

 

Sample size: the study was powered to detect a prevalence of 44% [27] at 80% power, a significance level of 5% and a 95% confidence level. Contingency to account for medical records with incomplete data was set at 10%, giving a minimum of 90% of the information in the participants´ medical records, which allowed for multiple imputations of missing data at the analysis level. The minimum required number of records was calculated at 380.

 

Data collection: the case records were obtained from the registry department and information on demographic and clinical characteristics of HIV infected pregnant women was extracted. Case definition of UTI: a UTI case was defined as a positive urine culture. For this data, a midstream urine sample of women admitted with symptoms suggestive of UTI was collected for culture. A laboratory technician performed a routine urine culture and confirmed positive results. We excluded women with a urine culture-negative (no growth), missing of documented urine culture test, multiple pregnancies, underlying renal disease and files with incomplete data. We used a simple random (computer-generated random numbers) sampling technique to select records without replacement. Once a medical record was selected, if the participant was ineligible, the record was not replaced.

 

Statistical methods: for descriptive statistics, the median (interquartile range [IQR]) for continuous values (i.e. age of the mother [years], gestational age and number of antenatal visits) was calculated after testing for the assumption of normality using Shapiro-Wilk W-test and QQ-plots graphically (result not shown). For the comparison of baseline characteristics, we used the aPearson chi-square test and bFisher´s exact test for categorical variables.

 

Investigator´s best model selection approach was used to ascertain a suitable multiple regression model to predict the presence of UTI from all variables known about the individual. We then used UTI case status as an outcome and selected variables as exposures to carry out bivariate analysis and subsequently included factors with P-value below 0.20 into an unconditional logistic regression model, employing the forward selection approach and level of significance of 0.05. The likelihood ratio test was used to drop out variables one by one from the model until we reached the priori set of variables (based on the investigator´s experience in Zambian clinical setting). A predicted probability distribution was done to illustrate the chance of UTIs given the gestational age of the pregnancy. To avoid inflating the type-I error rate and loss of power, continuous predictor variables (e.g. gestational age) were not categorised in the regression model. All statistical tests were done at the significance level of alpha 0.05 and 95% confidence interval. Data were analysed using Stata/FC version 15 (Stata Corporation, Texas, TX, USA).

 

Study variables

 

Independent variables: clinical and socio-demographic characteristics, age, marital status, number of antenatal visits, education level, gestational age and occupation. Dependent variable: UTI among pregnant women which was a binary qualitative variable and classified at two levels as presence versus absence.

 

Ethical statement: ethical clearance was granted by ERES converge ethics committee (approval number 2018-Feb-043) and additional permission was obtained from the management of the Women and Newborn Hospital. The confidentiality of all records was safeguarded to the extent ethically possible and all laboratory, reports, study data and data extraction forms are coded by numbers only. Databases are password protected.

 

 

Results Up    Down

Clinical and demographic characteristics of participants: we reviewed 380 medical records of pregnant women. With the Shapiro-Wilk normality test and Q-Q plots confirming data were not normally distributed, we determined that the median maternal age was 29 years (IQR: 22, 34) and median gestational age 36 weeks (IQR: 30.5, 39). Additionally, the median haemoglobin levels and parity of the participants were 11g/dl (IQR; 9.1, 12) and two children (IQR; 1, 3), respectively. The majority of them attended antenatal clinic at least three times 262 (69%), 303 (79.7%) were married, 76 (20%) were single and 1 (0.3%) was a widow. Furthermore, 159 (41.8%) had attained tertiary level education, 147 (38.7) secondary and 74 (19.5%) managed a primary level of education. The majority of the women 170 (44.7%) were in informal employment, 111 (29.2%) were unemployed and 99 (26.1%) were in formal employment (Table 1).

 

Prevalence of UTIs: of the 380 study participants, 63 had UTIs, translating to a prevalence of 16.5% (95% CI: 13.0, 20.7). From the total number of subjects in each category who were diagnosed with UTIs 25/159 (15.7%) attained tertiary level of education, 24/147 (16.3%) secondary level and 14/76 (18.4%) attained primary level education. Additionally, 11/99 (11.1%) were in formal employment, 31/170 (18.22%) were in the informal sector and 21/111 (18.9%) were unemployed, gestation age was less than 36 weeks 48/211 (22.7%), hard less than two children 42/240 (17.5%), had haemoglobin levels of less than 11 g/dl 36/194 (18.6%) and had visited antenatal clinic less than three times 46/262 (17.6%). There was a significant association between gestational age and UTIs (P<0.001). On the contrary, there was no association between maternal age, parity, occupation, marital status and education (Table 2).

 

Factors associated with UTIs at Women and New Born Hospital: regression analysis to predict the presence of UTI from all variables known about the participant was undertaken. Table 3 shows the results of the bivariate and multivariable analysis to assess factors associated with UTIs.

 

Bivariate analysis: single women compared to married (OR 1.61, 95% CI; 0.86, 3.00), women in informal (OR 1.78, 95% Cl; 0.85, 3.75) and unemployed (OR 1.87, 95% Cl; 0.85, 4.10) compared to those in formal employment had higher odds of being diagnosed with UTI. An increase in the number of antenatal visits (OR 0.88, 95% Cl; 0.69, 1.10) and age of a woman (OR 0.98, 95% Cl; 0.94, 1.20) reduced the odds of having UTI though random chance finding could not be ruled out. On the other hand, a unit increase in gestation reduced the odds of having a UTI (OR 0.95, 95% Cl; 0.91, 0.99).

 

Multivariable analysis: a unit increase in gestational age was independently associated with reduced odds of having a UTI (AOR 0.96, 95% Cl; 0.91, 0.99). This reduction could be as high as 0.99 to as low as 0.91, with probability 0.95 from the population where this sample came from. Additionally, being single (AOR 1.46, 95% Cl; 0.66, 3.22) and occupation (i.e. informal (AOR 1.76, 95% Cl; 0.84, 3.75), unemployed (AOR 1.71, 95% Cl; 0.77, 3.81) compared to formal) both increased the chance of UTIs though this was not significant. While education (i.e. secondary (AOR 0.79, 95% Cl; 0.37, 1.64) or tertiary (AOR 0.75, 95% Cl; 0.36, 1.59) compared to primary) and a unit increase in the number of antenatal visits (AOR 0.95, 95% Cl; 0.73, 1.18) predicted less chance of urinary tract infections controlling for all variables in the model though random chance finding could not be ruled out.

 

Predicted chance of UTI given gestational age of a woman: the predicted chance of UTIs given the gestational age of a woman is shown in Figure 1. Inferring from the figure, an increase in the gestational age of a woman reduced the chance of having UTIs.

 

 

Discussion Up    Down

This study assessed the prevalence and associated factors of UTIs among HIV infected pregnant women at Women and Newborn Hospital in Lusaka, Zambia. Our findings revealed a UTI prevalence of 16.5% in the period between 1st January 2017 to 31st December 2017 in this setting. An increase in gestational age predicted less chance of UTIs in this population. There was no significant association with maternal age, parity, occupation, marital status and education. This prevalence was relatively higher than the reported range of 1.9% to 10% in a recent systematic review and meta-analysis of the prevalence of asymptomatic bacteriuria [28]. However, analysis of regional estimates suggests higher trends that are comparable to our findings; 14.2% in Zimbabwe, 28% in Tanzania and 17.31% in Nigeria [2,29,30]. We only found a lower reported prevalence in South Africa of 5% [31]. This could suggest a higher disease burden in our settings or differences in the approach of these studies.

 

Another plausible explanation could be due to different admission criteria in different countries and hospitals and the fact that most cases during antenatal visits are managed on an outpatient basis. Besides, the populations studied differ. For example, the study by Kaduma [2] was a matched case-control study looking at the risk of UTIs in preeclampsia and non-preeclamptic controls, the controls alone had a prevalence of 16.8%. The other possible reason could be that the diagnosis criteria and infrastructure in the region is different from country to country. For instance, in the findings of a study done in South Africa, they reported that the cost of the standard urinary culture was a limiting factor for the routine urine screening [31]. It is for this reason that other screening methods have been proposed, which include urine dipsticks, gram staining, bioluminescence assays, microscopic urinalysis and dipslide urine cultures.

 

Omoregie and Eghafona (2016), in their study on UTIs among asymptomatic HIV patients in Benin-Nigeria, reported a significantly higher prevalence among HIV patients compared to non-HIV infected subjects (27.45% versus 17.31%, respectively, P=0.038) [30]. In the present study, we, however, did not review medical records for HIV-negative pregnant women and hence were not able to compare the differences. This is potentially for future work. The other aspect to the present findings is that the women were treated in similar fashion (tenofovir 300mg, lamivudine 300mg and efavirenz 400mg) which is currently the first line of treatment for HIV infection according to the Zambian national guidelines [32] and data was not available on the stage of the disease. This may have influenced the prevalence as persons with advanced stages of HIV infection are more prone to develop UTIs than those with well-controlled or undetectable viral load counts [30]. Other studies have found that HIV status does not play a role in the severity of the UTI [31,33]. Reasons could possibly be that the patients were on different antiretroviral drugs, which help to reconstitute the immune system and the severity of the HIV infection was not reported in their findings. Moreover, since the present study excluded incomplete medical records, it can be argued that the prevalence of UTI among HIV-infected pregnant women may be higher in this setting.

 

The findings further revealed that an increase in gestational age predicted less chance of UTIs controlling for other variables in the model. This is particularly important when planning public health interventional studies that need the targeted population at risk for UTIs. In a review based on critical assessment of literature by Schnnar J and Small F, 2008, of the pregnant women screened between 12 and 16 weeks gestation, 80% were identified to have asymptomatic bacteriuria [34]. In the Zambian setting, a higher proportion of pregnant women book for antenatal care in the late second trimester [35], presenting a challenge for early diagnosis and management. Up to 30-40% of pregnant women with asymptomatic bacteriuria develop symptomatic UTI later in pregnancy if ASB is undetected and untreated compared to 1.8% non-bacteriuric controls [35,36]. This complication may lead to adverse pregnancy outcomes like preterm birth, the premature rapture of membranes and pyelonephraitis [31]. Therefore, it is very important that screening is done at the booking visit [37].

 

Our findings bring out some important aspects with regard to gestational age. It is in the early weeks of pregnancy where the mothers are at increased risk for UTIs (Figure 1). Therefore increasing awareness to encourage early attendance for antenatal care services at the hospital can improve early diagnosis [34]. Most European and north American clinical practice guidelines recommend screening for ASB as a routine pregnancy test [38]. In the Zambian setting, just like in many other settings, screening related guidelines have not yet been implemented to optimise pregnancy outcomes through the use of evidence-based practice [29].

 

Limitations: the use of the retrospective design in research may affect the completeness and accuracy of data to be collected. Care was taken to only use records with atleast 90% complete information. External validity-single site study and lacks generalisability to other populations.

 

 

Conclusion Up    Down

The prevalence of UTIs among HIV-infected pregnant women at the Women and Newborn Hospital in Zambia is 16.5%. An increase in gestational age predicted less chance of UTIs in this population. Efforts to improve clinical outcomes of HIV-infected pregnant women should be directed at early screening for UTIs in this setting.

What is known about this topic

  • UTIs are a significant problem in pregnancy and if left untreated can lead to adverse pregnancy outcomes;
  • It affects HIV infected pregnant women more commonly than the HIV negative;
  • Sub-Saharan Africa shares this burden disproportionately when compared to other developed countries.

What this study adds

  • The prevalence of UTIs at a tertiary public health institution in Zambia;
  • Increase in gestational age predicts less chance of UTIs in this setting.

 

 

Competing interests Up    Down

The authors declare no conflict of interests.

 

 

Authors' contributions Up    Down

Mukosha Moses: conceptualization, data curation, investigation, writing original draft preparation, writing review and editing; Lukundo Nambela, data collection, investigation, writing review and editing; Bellington Vwalika: supervision, review and editing; Chiluba Mwila: review and editing; Micheal Chigunta: review and editing; Aubrey Kalungia C: review and editing, data curation; Ketty Mwansa Lubeya: review and editing. All the authors have read and agreed to the final manuscript.

 

 

Acknowledgments Up    Down

The authors would like to acknowledge the mothers and members of staff at Women and New Born Hospital, Lusaka, Zambia.

 

 

Tables and figure Up    Down

Table 1: clinical and social demographic characteristics of selected participants at women and new-born hospital, 2017 (n=380)

Table 2: prevalence of UTI and characteristics of study participants with UTI

Table 3: factors associated with UTI at women and new born hospital

Figure 1: the predicted probability of urinary tract infections given the gestational age of the pregnant woman

 

 

References Up    Down

  1. Chaula T, Seni J, Ng´walida N, Kajura A, Mirambo MM, DeVinney R et al. Urinary tract infections among HIV-positive pregnant women in Mwanza city, Tanzania, are high and predicted by low CD4+ Count. Int J Microbiol. 2017;2017:4042686. PubMed | Google Scholar

  2. Kaduma J, Seni J, Chuma C, Kirita R, Mujuni F, Mushi MF et al. Urinary tract infections and preeclampsia among pregnant women attending two hospitals in Mwanza City, Tanzania: A 1: 2 matched case-control study. Biomed Res Int. 2019;2019:3937812. PubMed | Google Scholar

  3. Marami D, Balakrishnan S, Seyoum B. Prevalence, antimicrobial susceptibility pattern of bacterial isolates and associated factors of urinary tract infections among HIV-positive patients at Hiwot Fana Specialized University Hospital, eastern Ethiopia. Can J Infect Dis Med Microbiol. 2019;2019:6780354. PubMed | Google Scholar

  4. Bebell LM, Ngonzi J, Siedner MJ, Muyindike WR, Bwana BM, Riley LE et al. HIV infection and risk of postpartum infection, complications and mortality in rural Uganda. AIDS Care. 2018;30(8):943-953. PubMed | Google Scholar

  5. Boafor T, Olayemi E, Galadanci N, Hayfron-Benjamin C, Dei-Adomakoh Y, Segbefia C et al. Pregnancy outcomes in women with sickle-cell disease in low and high income countries: a systematic review and meta-analysis. BJOG. 2016;123(5):691-698. PubMed | Google Scholar

  6. Tandogdu Z, Wagenlehner FM. Global epidemiology of urinary tract infections. Curr Opin Infect Dis. 2016;29(1):73-79. PubMed | Google Scholar

  7. Arab K, Spence AR, Czuzoj-Shulman N, Abenhaim HA. Pregnancy outcomes in HIV-positive women: a retrospective cohort study. Arch Gynecol Obstet. 2017;295(3):599-606. PubMed | Google Scholar

  8. Enwonwu CO. Complex interactions between malnutrition, infection and immunity: relevance to HIV/AIDS infection. Nigerian Journal of Clinical and Biomedical Research. 2006;1(1):6-14. Google Scholar

  9. Tadesse S, Kahsay T, Adhanom G, Kahsu G, Legese H, Wahid A et al. Prevalence, antimicrobial susceptibility profile and predictors of asymptomatic bacteriuria among pregnant women in Adigrat General Hospital, Northern Ethiopia. BMC Res Notes. 2018;11(1):740. PubMed | Google Scholar

  10. Chu CM, Lowder JL. Diagnosis and treatment of urinary tract infections across age groups. Am J Obstet Gynecol. 2018;219(1):40-51. PubMed | Google Scholar

  11. Almomani BA, Hayajneh WA, Ayoub AM, Ababneh MA, Al Momani MA. Clinical patterns, epidemiology and risk factors of community-acquired urinary tract infection caused by extended-spectrum beta-lactamase producers: a prospective hospital case-control study. Infection. 2018;46(4):495-501. PubMed | Google Scholar

  12. Skrzat-Klapaczynska A, Matlosz B, Bednarska A, Paciorek M, Firlag-Burkacka E, Horban A et al. Factors associated with urinary tract infections among HIV-1 infected patients. PLOS One. 2018;13(1):e0190564. PubMed | Google Scholar

  13. Ghouri F, Hollywood A, Ryan K. A systematic review of non-antibiotic measures for the prevention of urinary tract infections in pregnancy. BMC Pregnancy Childbirth. 2018;18(1):99. PubMed | Google Scholar

  14. Yan L, Jin Y, Hang H, Yan B. The association between urinary tract infection during pregnancy and preeclampsia: a meta-analysis. Medicine (Baltimore). 2018;97(36):e12192. PubMed | Google Scholar

  15. Chababa L, Mukosha M, Sijumbila G, Vwalika B. Relationship between serum zinc levels and preeclampsia at the University Teaching Hospital, Lusaka, Zambia. Medical Journal of Zambia. 2016;43(3):139-144. Google Scholar

  16. Kwangu M, Yassa P, Lambwe N, Mukosha M, Sijumbila G. Interplay between nitric oxide (NO) and glucose 6-phosphate dehydrogenase (G6PD) activity in primary hypertension. International Journal of Medicine and Medical Sciences. 2014;6(7):165-170. Google Scholar

  17. Ezechi O, Gab-Okafor C, Oladele D, Kalejaiye O, Oke B, Ohwodo H et al. Pregnancy, obstetric and neonatal outcomes in HIV positive Nigerian women. Afr J Reprod Health. 2013;17(3):160-168. PubMed | Google Scholar

  18. Masinde A, Gumodoka B, Kilonzo A, Mshana S. Prevalence of urinary tract infection among pregnant women at Bugando Medical Centre, Mwanza, Tanzania. Tanzan J Health Res. 2009;11(3):154-9. PubMed | Google Scholar

  19. Mazor-Dray E, Levy A, Schlaeffer F, Sheiner E. Maternal urinary tract infection: is it independently associated with adverse pregnancy outcome. J Matern Fetal Neonatal Med. 2009;22(2):124-128. PubMed | Google Scholar

  20. O'Malley K, Suharwardy S, Sie L, Lee HC, Gibbs RS, Aziz N. Adverse pregnancy outcomes among women with urinary tract infections: comparing sensitive and resistant organisms [27C]. Obstetrics & Gynecology. 2017;129(5):37S. Google Scholar

  21. Kazemier BM, Koningstein FN, Schneeberger C, Ott A, Bossuyt PM, de Miranda E et al. Maternal and neonatal consequences of treated and untreated asymptomatic bacteriuria in pregnancy: a prospective cohort study with an embedded randomised controlled trial. Lancet Infect Dis. 2015;15(11):1324-1333. PubMed | Google Scholar

  22. Matuszkiewicz-Rowinska J, Malyszko J, Wieliczko M. Urinary tract infections in pregnancy: old and new unresolved diagnostic and therapeutic problems. Arch Med Sci. 2015;11(1):67-77. PubMed | Google Scholar

  23. Farkash E, Weintraub AY, Sergienko R, Wiznitzer A, Zlotnik A, Sheiner E. Acute antepartum pyelonephritis in pregnancy: a critical analysis of risk factors and outcomes. Eur J Obstet Gynecol Reprod Biol. 2012;162(1):24-27. PubMed | Google Scholar

  24. Berti F, Attardo TM, Piras S, Tesei L, Tirotta D, Tonani M et al. Short versus long course antibiotic therapy for acute pyelonephritis in adults: a systematic review and meta-analysis. Italian Journal of Medicine. 2018;12(1):39-50. Google Scholar

  25. Kim SJ, Parikh P, King AN, Marnach ML. Asymptomatic bacteriuria in pregnancy complicated by pyelonephritis requiring nephrectomy. Case Rep Obstet Gynecol. 2018;2018:8924823. PubMed | Google Scholar

  26. Yagel Y, Nativ H, Riesenberg K, Nesher L, Saidel-Odes L, Smolyakov R. Outcomes of UTI and bacteriuria caused by ESBL vs non-ESBL Enterobacteriaceae isolates in pregnancy: a matched case-control study. Epidemiol Infect. 2018;146(6):771-774. PubMed | Google Scholar

  27. Chisanga J, Mazaba M, Mufunda J, Besa C, Kapambwe-muchemwa M, Siziya S. Antimicrobial susceptibility patterns and their correlate for urinary tract infection pathogens at Kitwe Central Hospital, Zambia. Health Press Zambia Bull. 2017;1(1). Google Scholar

  28. Ghafari M, Baigi V, Cheraghi Z, Doosti-Irani A. The prevalence of asymptomatic bacteriuria in Iranian pregnant women: a systematic review and meta-analysis. PloS One. 2016;11(6):0158031. PubMed | Google Scholar

  29. Rukweza J, Nziramasanga P, Gidiri M, Haruzivishe C, Pedersen B. Antibiotic susceptibility of bacterial strains causing asymptomatic bacteriuria in pregnancy: a cross-sectional study in Harare, Zimbabwe. MOJ Immunol. 2018;6(1):00184. Google Scholar

  30. Ogefere HO, Osikobia JG, Omoregie R. Prevalence of AmpC β-lactamase among gram-negative bacteria recovered from clinical specimens in Benin City, Nigeria. Tropical Journal of Pharmaceutical Research. 2016;15(9):1947-1953. Google Scholar

  31. Siemefo Kamgang FdP, Maise HC, Moodley J. Pregnant women admitted with urinary tract infections to a public sector hospital in South Africa: are there lessons to learn. Southern African Journal of Infectious Diseases. 2016;31(3):79-83. Google Scholar

  32. Mubiana-Mbewe M, Bosomprah S, Kadota JL, Koyuncu A, Kusanathan T, Mweebo K et al. Effect of enhanced adherence package on early ART uptake among HIV-positive pregnant women in Zambia: an individual randomized controlled trial. AIDS Behav. 2020. PubMed | Google Scholar

  33. Widmer TA, Theron G, Grove D. Prevalence and risks of asymptomatic bacteriuria among HIV-positive pregnant women. Southern African Journal of Epidemiology and Infection. 2010;25(1):28-32. Google Scholar

  34. Schnarr J, Smaill F. Asymptomatic bacteriuria and symptomatic urinary tract infections in pregnancy. Eur J Clin Invest. 2008;38 Suppl 2:50-57. PubMed | Google Scholar

  35. Lubeya MK, Vwalika B. Anaemia in pregnancy among pregnant women in Lusaka District, Zambia. Medical Journal of Zambia. 2017;44(4):238-243. Google Scholar

  36. Whalley P. Bacteriuria of pregnancy. Am J Obstet Gynecol. 1967;97(5):723-738. PubMed | Google Scholar

  37. Gilstrap III LC, Ramin SM. Urinary tract infections during pregnancy. Obstet Gynecol Clin North Am. 2001;28(3):581-591. PubMed | Google Scholar

  38. Angelescu K, Nussbaumer-Streit B, Sieben W, Scheibler F, Gartlehner G. Benefits and harms of screening for and treatment of asymptomatic bacteriuria in pregnancy: a systematic review. BMC Pregnancy Childbirth. 2016;16(1):336. PubMed | Google Scholar

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research

Urinary tract infections and associated factors in HIV infected pregnant women at a tertiary hospital in Lusaka, Zambia

Research

Urinary tract infections and associated factors in HIV infected pregnant women at a tertiary hospital in Lusaka, Zambia

Research

Urinary tract infections and associated factors in HIV infected pregnant women at a tertiary hospital in Lusaka, Zambia